Triazine angiogenesis inhibitors
Compounds having Formula (I) or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to methods of inhibiting an...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
05.07.1999
|
Edition | 6 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Compounds having Formula (I) or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to methods of inhibiting angiogenesis in a mammal. |
---|---|
AbstractList | Compounds having Formula (I) or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to methods of inhibiting angiogenesis in a mammal. |
Author | DONALD J. DAVIDSON RICHARD W. MCCROSKEY GEORGE S SHEPPARD JACK HENKIN KEITH W. WOODS |
Author_xml | – fullname: DONALD J. DAVIDSON – fullname: KEITH W. WOODS – fullname: JACK HENKIN – fullname: GEORGE S SHEPPARD – fullname: RICHARD W. MCCROSKEY |
BookMark | eNrjYmDJy89L5WRQCCnKTKzKzEtVSMxLz8xPT81LLc4sVsjMy8hMyizJLyrmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyUAtJfGOoYYWhhamlpaOxoRVAADO6Sba |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 6 |
ExternalDocumentID | AU1818599A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU1818599A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:54:02 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU1818599A3 |
Notes | Application Number: AU1818599 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990705&DB=EPODOC&CC=AU&NR=1818599A |
ParticipantIDs | epo_espacenet_AU1818599A |
PublicationCentury | 1900 |
PublicationDate | 19990705 |
PublicationDateYYYYMMDD | 1999-07-05 |
PublicationDate_xml | – month: 07 year: 1999 text: 19990705 day: 05 |
PublicationDecade | 1990 |
PublicationYear | 1999 |
RelatedCompanies | ABBOTT LABORATORIES |
RelatedCompanies_xml | – name: ABBOTT LABORATORIES |
Score | 2.5051906 |
Snippet | Compounds having Formula (I) or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Triazine angiogenesis inhibitors |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990705&DB=EPODOC&locale=&CC=AU&NR=1818599A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3JTsMwEB2VgoAbFFDZc0C5WSSNsx0q1GZRhdRFKEW9VXbqtL6kFQni9xmHBLj0ZtnSeJFnxs_2vAF48j3GHMtMid8TnNCMpsQzbUYsbjoIOHxmrdR9x3jijOb0dWEvWrBpYmEqntCvihwRNSpFfS8re737u8QKq7-VxTOXWLV9iZN-qK_qcDGEeoath8N-NJuG00APAkSS-uQNlRwdk-8PDuBQHaIVy370PlQxKbv_DiU-g6MZysrLc2iJvAMnQZN3rQPH4_q5G4u15hUXoCW4UxQTtMbytdyulYmShSbzjeRSZcy5hMc4SoIRwa6Wv7NaDubNmKwraCPWF13Q3J7wBOWWZ6QGpYocLHMYyxwjo-7Ko_Y1dPdJudnfdAunP2wDLjHsO2iXH5_iHn1pyR-qZfgGCaV41Q |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8JAEJ4gGvGmqMEnPZjeGlu6fR2IgZamKi3EFMONbF-wl0JsjX_f6dqqF26b3WT2kZ2ZfLM73wA8WCaluqrEkjVII4lkJJZMRaOSGik6Ag6LqkkV7_AD3VuQl6W2bMGmyYXhPKFfnBwRNSpGfS-5vd79BbEc_reyeIwYdm2f3HDoiEmdLoZQT9ZEZzyczGfOzBZtG5GkGLyhkqNjsqzRARwaCAg5UHofVzkpu_8OxT2FoznKysszaKV5Fzp2U3etC8d-_dyNzVrzinMQQrwpFRO0QPM1264rE8UKgeUbFrGqYs4F9N1JaHsSTrX63dVqtGjWpF5CG7F-2gPBGKRmSiLVlGOZkIocLNMpzXQ5I0ZiEu0KevukXO8f6kPHC_3pavocvN7AyQ_zgCHJ2i20y4_P9A79ahnd8yP5BtOoe78 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Triazine+angiogenesis+inhibitors&rft.inventor=DONALD+J.+DAVIDSON&rft.inventor=KEITH+W.+WOODS&rft.inventor=JACK+HENKIN&rft.inventor=GEORGE+S+SHEPPARD&rft.inventor=RICHARD+W.+MCCROSKEY&rft.date=1999-07-05&rft.externalDBID=A&rft.externalDocID=AU1818599A |